Alluvi tirzepatide is emerged as a promising therapeutic candidate for the management of metabolic conditions. This initial evaluation investigated the efficacy and tolerability of tirzepatide 40mg in animal models of insulin resistance. The experiments demonstrated that tirzepatide 40mg markedly improved glycemic control and reduced insulin resist